跳至主要内容
临床试验/NCT06094322
NCT06094322已完成不适用

Advanced DL-based T2w and DWI MR Sequences for Prostate Imaging

Centre Hospitalier Universitaire, Amiens2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2022年7月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
34
试验地点
2
主要终点
Change in number of suspicious nodule prostate detection before and after rapid T2-weighted

研究概览

简要总结

MR prostate exam is essential for the diagnosis, workup and follow-up of prostate cancer. It allows to detect subclinical prostate cancer following an increase in the level of PSA. The investigators can score the lesion according to the PIRADS classification and obtain an estimate of lesion malignancy. To perform this classification, T2 and DWI sequences are essential.

Detection and characterization of malignant lesion is important to address appropriate patient care pathway. The purpose of this project is to evaluate novel deep learning (DL) T2-weighted TSE (T2DL) and Diffusion (DWIDL) sequences for prostate MR exam and investigate its impact on diagnostic, examination time, image quality, and PI-RADS classification compared to standard T2-weighted TSE (T2S) and standard Diffusion (DWIS) sequences.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 ans
  • Healthy subject without history of hepatic disease
  • Patient addressed for an prostate MRI
  • Ability to give consent

排除标准

  • claustrophobia,
  • major obesity (>140 kg),
  • Patient under guardianship or curators
  • Age < 18 years,
  • History of prostatectomy or irradiation of the prostate
  • any contraindication to MRI exam

结局指标

主要结局

Change in number of suspicious nodule prostate detection before and after rapid T2-weighted

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Evaluation of Rapid T2-weighted and DWI MR Sequences... | 临床试验